Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of John F. McDonald as an independent member of its Board of Directors, effective September 7, 2022.“With his three decades in the biopharmaceutical industry across...

Related Keywords

Berkeley ,California ,United States ,University Of California Hastings College The Law ,Ukraine ,Johnf Mcdonald ,Johna Scarlett ,Novo Nordisk ,University Of California ,Geron Corporation Nasdaq ,Global Rd Business Development ,Genentech Inc ,Biogen Inc ,Millennium Pharmaceuticals Inc ,Exchange Commission ,Genzyme Corp ,Haas School Of Business ,Takeda Oncology Company ,Roche Group ,Mcdonald ,Business Development ,Geron Corporation ,Chief Executive ,Corporate Vice President ,Vice President ,Managing Director ,Millennium Pharmaceuticals ,California Hastings College ,Haas School ,Private Securities Litigation Reform Act ,